VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Nov 05, 2024 7:30am

35 Views

Post# 36296583

Good comment on post Children's National Innovation Ventures

Interesting Richard Simpson on Linkedin commented

Richard Simpson • Following

10h

Ventripoint Diagnostics Ltd.: FDA/EU/CA/NZL approved AI-based echocardiography product with pediatrics as primary focus. Existing users include Duke (2 systems), Sick Kids, Seattle Children's, Evelina, East Midlands, Vienna Children's, German Heart Center. Major support from Ollie Hinkle Heart Foundation

To support the global need for innovation in pediatric medical device development, Kolaleh Eskandanian, PhD, MBA, PMP, vice president and chief innovation officer, is serving as advisor to DeCODe, a new European Commission-funded medical device consortium formed to catalyze innovation and address the unique healthcare needs of children with rare diseases.

Dr. Eskandanian, who has 11 years of success in leading an FDA-funded pediatric device consortium as principal investigator and director, will share best practices and lessons learned from her experience to help DeCODe as they work to advance medical devices that will help address the unmet needs of children. This collaboration highlights the importance of global partnerships to ensure that childrencan access innovative medical technologies designed specifically for them regardless of where they live. Children's National Hospital is proud to partner with DeCODe for the benefit of children everywhere.

EU4Health Medicaldevices Innovate4Kids Devices4Kids

Anneliene Jonker Tom Melvin Hayley Every Akvile Zalatoryte, MSc, VBHC Green Belt Fenna Mahler Ricardo Fernandes Prof Dr Wout Feitz, MD, PhD, FEBU, FEAPU. Michelle Battye Marc Dooms Vincenzo Carbone, PhD Annalisa Sechi Dr Donal O'Connor Virginie HIVERT

Children's National-led consortium collaborates with European consortium to accelerate innovation | Children's National Hospital

childrensnational.org

( Ventripoint Diagnostics Ltd.: FDA/EU/CA/NZL approved AI-based echocardiography product with pediatrics as primary focus. Existing users include Duke (2 systems), Sick Kids, Seattle Children's, Evelina, East Midlands, Vienna Children's, German Heart Center. Major support from Ollie Hinkle Heart Foundation) this post Children's National Innovation VenturesChildren's National Innovation Ventures 2 weeks ago To support the global need for innovation in pediatric medical device development, Kolaleh Eskandanian, PhD, MBA, PMP, vice president and chief innovation officer, is serving as advisor to DeCODe, a new European Commission-funded medical device consortium formed to catalyze innovation and address the unique healthcare needs of children with rare diseases. Dr. Eskandanian, who has 11 years of success in leading an FDA-funded pediatric device consortium as principal investigator and director, will share best practices and lessons learned from her experience to help DeCODe as they work to advance medical devices that will help address the unmet needs of children. This collaboration highlights the importance of global partnerships to ensure that childrencan access innovative medical technologies designed specifically for them regardless of where they live. Children's National Hospital is proud to partner with DeCODe for the benefit of children everywhere. https://www.childrensnational.org/about-us/newsroom/2024/childrens-national-led-consortium-collaborates-with-european-consortium-to-accelerate-innovation

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles